Skip to Content
Merck
  • Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.

Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.

Advanced healthcare materials (2014-06-25)
Jesper Hjortnaes, Gulden Camci-Unal, Joshua D Hutcheson, Sung Mi Jung, Frederick J Schoen, Jolanda Kluin, Elena Aikawa, Ali Khademhosseini
ABSTRACT

Three dimensional (3D) hydrogel platforms are powerful tools, providing controllable, physiologically relevant microenvironments that could aid in understanding how various environmental factors direct valvular interstitial cell (VIC) phenotype. Continuous activation of VICs and their transformation from quiescent fibroblast to activated myofibroblast phenotype is considered to be an initiating event in the onset of valve disease. However, the relative contribution VIC phenotypes is poorly understood since most 2D culture systems lead to spontaneous VIC myofibroblastic activation. Here, a hydrogel platform composed of photocrosslinkable versions of native valvular extracellular matrix components-methacrylated hyaluronic acid (HAMA) and methacrylated gelatin (GelMA)-is proposed as a 3D culture system to study VIC phenotypic changes. These results show that VIC myofibroblast-like differentiation occurs spontaneously in mechanically soft GelMA hydrogels. Conversely, differentiation of VICs encapsulated in HAMA-GelMA hybrid hydrogels, does not occur spontaneously and requires exogenous delivery of TGFβ1, indicating that hybrid hydrogels can be used to study cytokine-dependent transition of VICs. This study demonstrates that a hybrid hydrogel platform can be used to maintain a quiescent VIC phenotype and study the effect of environmental cues on VIC activation, which will aid in understanding pathobiology of valvular disease.

MATERIALS
Product Number
Brand
Product Description

Sodium hydroxide concentrate, 0.1 M NaOH in water (0.1N), Eluent concentrate for IC
Sigma-Aldrich
Calcein-AM, Small Package (20 X 50 μg ), ≥90.0% (HPLC)
Sodium hydroxide, BioUltra, suitable for luminescence, ≥98.0% (T), pellets
Sodium hydroxide solution, 49-51% in water, eluent for IC
Sodium hydroxide solution, BioUltra, Molecular Biology, 10 M in H2O
Sigma-Aldrich
Methacrylic anhydride, contains 2,000 ppm topanol A as inhibitor, ≥98%
Sigma-Aldrich
Calcein-AM, suitable for fluorescence, BioReagent, ≥90% (HPLC)
Sodium hydroxide solution, 1.0 N, BioReagent, suitable for cell culture
3-Ethyl-2,4-pentanedione, mixture of tautomers, 98%
Sodium hydroxide, ultra dry, powder or crystals, 99.99% trace metals basis
Sodium hydroxide, AR, pellets, ≥98.5%
Sodium hydroxide, puriss. p.a., ACS reagent, K ≤0.02%, ≥98.0% (T), pellets
Sodium hydroxide, reagent grade, 97%, powder
Sodium hydroxide solution, 5.0 M
Sodium hydroxide, BioXtra, ≥98% (acidimetric), pellets (anhydrous)
Sodium hydroxide, puriss., meets analytical specification of Ph. Eur., BP, NF, E524, 98-100.5%, pellets
Sodium hydroxide solution, purum, ≥32%
Sodium hydroxide, beads, 16-60 mesh, reagent grade, 97%
Sodium hydroxide, reagent grade, 97%, flakes
Sodium hydroxide solution, 50% in H2O
Sodium hydroxide, ACS reagent, ≥97.0%, pellets
Sodium hydroxide, pellets, semiconductor grade, 99.99% trace metals basis
Sodium hydroxide, puriss. p.a., ACS reagent, reag. Ph. Eur., K ≤0.02%, ≥98%, pellets
Sodium hydroxide, reagent grade, ≥98%, pellets (anhydrous)
Sodium hydroxide, anhydrous, free-flowing, Redi-Dri, reagent grade, ≥98%, pellets
Sodium hydroxide-16O solution, 20 wt. % in H216O, 99.9 atom % 16O
DAPI, for nucleic acid staining
Calcein AM solution, 4 mM in DMSO, ≥90% (HPLC), solution